Image from Google Jackets

Normal view MARC view ISBD view

Concepcion lauds FDA decision allowing use of AstraZeneca for persons below 60 / by Genalyn Kabiling

By:

Kabiling, Genalyn

Subject(s):

Online resources:

Click here to access online

Summary: https://mb.com.ph/2021/04/19/concepcion-lauds-fda-decision-allowing-use-of-astrazeneca-for-persons-below-60/

Hello from Record Display Customizations!

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Cover image	Item type	Current library	Home library	Collection	Shelving location	Call number	Materials specified	Vol info	URL	Copy number	Status	Notes	Date due	Barcode	Item holds	Item hold queue priority	Course reserves
	News Clippings	DOH Central Library Electronic Resource Section				042021-016 (Browse shelf(Opens below))					Available			D0001NC042021-016

Browsing DOH Central Library shelves,Shelving location: Electronic Resource Section Close shelf browser (Hides shelf browser)

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
Previous	042021-013 Cebu City starts jabbing senior citizens /	042021-014 9 emergency field hospitals set up by PH Red Cross at Lung Center /	042021-015 PRC sets up 9 field hospitals at Lung Center /	042021-016 Concepcion lauds FDA decision allowing use of AstraZeneca for persons below 60 /	042021-017 ARTA to ensure green lane for vaccine manufacturers /	042021-018 FDA: Off-label use of Ivermectin is not illegal /	NC042621-001 Leni tells gov’t: Stop witch-hunt on community pantry organizers /	Next

https://mb.com.ph/2021/04/19/concepcion-lauds-fda-decision-allowing-use-of-astrazeneca-for-persons-below-60/

There are no comments on this title.

to post a comment.